Y-mAbs Therapeutics Inc (YMAB)
12.40
-0.45
(-3.50%)
USD |
NASDAQ |
May 23, 16:00
12.41
+0.01
(+0.08%)
Pre-Market: 20:00
Y-mAbs Therapeutics Free Cash Flow: -17.58M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -17.58M |
| December 31, 2023 | -27.23M |
| September 30, 2023 | -27.86M |
| June 30, 2023 | -45.75M |
| March 31, 2023 | -64.12M |
| December 31, 2022 | -75.92M |
| September 30, 2022 | -101.12M |
| June 30, 2022 | -99.96M |
| March 31, 2022 | -95.62M |
| December 31, 2021 | -103.52M |
| September 30, 2021 | -86.94M |
| Date | Value |
|---|---|
| June 30, 2021 | -93.04M |
| March 31, 2021 | -101.88M |
| December 31, 2020 | -91.41M |
| September 30, 2020 | -99.39M |
| June 30, 2020 | -97.16M |
| March 31, 2020 | -83.64M |
| December 31, 2019 | -75.46M |
| September 30, 2019 | -63.37M |
| June 30, 2019 | -50.60M |
| March 31, 2019 | -48.46M |
| December 31, 2018 | -41.23M |
Free Cash Flow Range, Past 5 Years
-103.52M
Minimum
Dec 2021
-17.58M
Maximum
Mar 2024
-75.08M
Average
-85.29M
Median
Free Cash Flow Benchmarks
| The Cooper Companies Inc | 136.00M |
| Puma Biotechnology Inc | 35.61M |
| Humacyte Inc | -83.53M |
| NovaBay Pharmaceuticals Inc | -4.524M |
| Palatin Technologies Inc | -33.83M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.477M |
| Cash from Financing (Quarterly) | 0.588M |
| Free Cash Flow Per Share (Quarterly) | -0.0794 |
| Free Cash Flow to Equity (Quarterly) | -3.477M |
| Free Cash Flow to Firm (Quarterly) | -3.477M |
| Free Cash Flow Yield | -3.25% |